Retrospective analysis of re-irradiation in malignant glioma: A single-center experience

Wiener Klinische Wochenschrift

Volumn 117, Issue 23-24, 2005, Pages 821-826

  Bartsch, Rupert ^a   Weitmann, Hajo Dirk ^a   Pennwieser, Wolfgang ^a   Wenzel, Catharine ^a   Muschitz, Sabine ^a   Baldass, Mike ^a   Hassler, Marco ^a   Marosi, Christine ^a   Rössler, Karl ^a   Pötter, Richard ^a   Dieckmann, Karin ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Palliative chemotherapy; Re irradiation; Re treatment; Recurrent malignant glioma; Stereotactic irradiation

Indexed keywords

ANTINEOPLASTIC AGENT; DACARBAZINE; FLUORODEOXYGLUCOSE; FOTEMUSTINE; GEFITINIB; IMATINIB; LOMUSTINE; METHIONINE; TEMOZOLOMIDE; THALIDOMIDE;

ADOLESCENT; ADULT; AGED; APHASIA; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GLIOBLASTOMA; GLIOMA; HUMAN; KAPLAN MEIER METHOD; LINEAR ACCELERATOR; MALE; MEMORY DISORDER; MULTIMODALITY CANCER THERAPY; NAUSEA; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RETROSPECTIVE STUDY; STEREOTAXIC SURGERY; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR RECURRENCE; TUMOR VOLUME; VOMITING;

ADOLESCENT; ADULT; AGED; AUSTRIA; BRAIN NEOPLASMS; CHILD; FEASIBILITY STUDIES; FEMALE; GLIOMA; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOSURGERY; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 32144450852     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-005-0475-z     Document Type: Article

References (27)

1. Burton EC, Prados MD (2000) Malignant gliomas. Curr Treat Options Oncol 1: 459-468
2. Simpson JR, Horton J, Scott C, et al (1993) Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: Results of three consecutive radiation therapy oncology group (RTOC) clinical trials. Int J Radiat Oncol Biol Phys 26: 239-244
3. Pan E, Prados MD (2004) Translational research in neuro-oncology. ASCO Educational book 120-131
4. Lanzetta G, Campanello C, Rozzi A, et al (2003) Temozolamide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial. Anticancer Res 23: 5159-5164
5. Stupp R, Mason WP, van den Bent MJ, et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996
6. Fazeny-Dorner B, Gyries A, Rossler K, et al (2003) Survival improvement in patients with glioblastoma multiforme during the last 20 years in a single tertiary-care center. Wien Klin Wochenschr 115: 389-397
7. Buckner JC (2003) Factors influencing survival in highgrade gliomas. Semin Oncol 30 [6 Suppl 19]: 10-14
8. Fazeny-Dorner B, Veitl M, Wenzel C, et al (2003) Secondline chemotherapy with dacarbacine and fotemustine in nitrosourea-pretreated patients with recurrent glioblastoma multiforme. Anticancer Drugs 14: 437-442
9. Tatter SB (2002) Recurrent malignant glioma in adults. Curr Treat Options Oncol 3: 509-524
10. The Medical Research Council Brain Tumour Working Party (2001) Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high grade astrozytoma: a medical research council trial. J Clin Oncol 19: 509-518
11. Hau P, Baumgart U, Pfeifer K, et al (2003) Salvage therapy in patients with glioblastoma: is there any benefit? Cancer 98: 2678-2686
12. Kaplan EL, Meier P (1958) Non parametric estimation for incomplete observations. J Am Stat Ass 53: 457-481
13. Kim HK, Thornton AF, Greenberg HS, et al (1997) Results of re-irradiation of primary intracranial neoplasms with three-dimensional conformal therapy. Am J Clin Oncol 20: 358-363
14. Vitanovics D, Sipos L, Afra D (2002) BCNU-DBD chemotherapy of recurrent supratentorial anaplastic astrocytomas and glioblastomas. Neoplasma 49: 342-345
15. Brada M, Hoang-Xuan K, Rampling R, et al (2001) Multicenter phase II trial of temozolamide in patients with glioblastoma multiforme at first relaps. Ann Oncol. 12: 259-266
16. Yung WK, Prados MD, Yaya-Tur R, et al (1999) Multicenter phase II trial of temozolamide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. J Clin Oncol 17: 2762-2771
17. Mühlbauer M, Gebhart E, Pfisterer W, et al (2002) Microsurgery for glioblastoma preserves short-term quality of life both in functionally impaired and independent patients. Wien Klin Wochenschr 114: 886-873
18. Nieder C, Grosu AL, Molls M (2000) A comparison of treatment results for recurrent malignant gliomas. Cancer Treat Rev 26: 397-409
19. Vordermark D, Kolbl O, Ruprecht K, et al (2005) Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma. BMC Cancer 5: 55
20. Arcicasa M, Roncadin M, Bidoli E, et al (1999) Reirradiation and lomustine in patients with relapsed high-grade gliomas. Int J Radiat Oncol Biol Phys 43: 789-793
21. Bhatnagar A, Heron DE, Kondziolka D, et al (2002) Analysis of repeat stereotactically radiosurgery for progressive primary and metastatic CNS tumors. Int J Radiat Oncol Biol Phys 53: 527-532
22. Combs SE, Ahmadi R, Schulz-Ertner D, et al (2005) Recurrent low-grade gliomas: the role of fractionated stereotactically re-irradiation. J Neuroncol 71: 319-323
23. Veninga T, Langendijk HA, Slotman BJ, et al (2001) Reirradiation of primary brain tumours: survival, clinical response and prognostic factors. Radiother Oncol 58: 127-137
24. Bauman GS, Sneed PK, Wara WM, et al (1996) Reirradiation of primary CNS tumors. Int J Radiat Oncol Biol Phys 36: 433-441
25. Lindvall P, Bergstrom P, Lofroth PQ, et al (2005) Hypofractionated conformal stereotactic radiotherapy alone or in combination with whole-brain radiotherapy in patients with cerebral metastases. Int J Radiat Oncol Biol Phys 61: 1460-1466
26. Holdhoff M, Kreuzer KA, Appelt C, et al (2005) Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptor. Blood Cells Mol Dis 34: 181-185
27. Rich JN, Reardon DA, Peery T, et al (2004) Phase II trial of gefitinib in recurrent glioblastoma. J Clin Oncol 22: 133-142